Mounjaro (tirzepatide) does not cure or permanently reverse type 2 diabetes, but by lowering blood sugar and driving significant weight loss it can help some people reach what doctors call remission — blood glucose in the non-diabetic range without glucose-lowering medication. Remission is possible but not guaranteed, is more likely earlier in the condition, and can reverse if weight returns. Mounjaro is a prescription-only medicine available in the UK only after a clinical consultation.
What does "reversing" type 2 diabetes actually mean?
In type 2 diabetes, "reversal" is more accurately described as remission: an HbA1c (a three-month average blood sugar marker) in the non-diabetic range, sustained without glucose-lowering medicines. The underlying tendency toward raised blood sugar does not disappear, which is why doctors avoid the word "cure".
Remission matters because weight loss can reduce fat in the liver and pancreas, allowing the body to use its own insulin more effectively. If body weight rises again, blood sugar can climb back into the diabetic range, so remission needs maintaining rather than a one-off event.
How does Mounjaro affect blood sugar and diabetes?
Mounjaro (tirzepatide) activates two gut-hormone receptors at once — GLP-1 and GIP. This helps the body release insulin when blood sugar is high, reduces the amount of glucose the liver produces, slows stomach emptying and reduces appetite, so you feel fuller sooner and for longer.
Those combined effects lower blood sugar directly and support substantial weight loss, and weight loss is the single biggest driver of type 2 diabetes remission. You can read more about how it works on the Mounjaro page.
How much weight can you lose on Mounjaro?
In the SURMOUNT-1 trial, participants on the 15mg dose lost on average 22.5% of body weight over 72 weeks, alongside lifestyle support. Individual results vary; not everyone reaches this.
Weight loss on this scale is clinically meaningful because research consistently links the amount of weight lost to the likelihood of improved blood sugar and, in some people, remission. Mounjaro is taken as a weekly self-injection, started at 2.5mg and increased gradually under prescriber review to a maximum licensed dose of 15mg.
Who is most likely to achieve remission?
Remission is generally more achievable the earlier it is attempted and the more weight is lost. The following factors are commonly associated with a better chance of reaching the non-diabetic blood sugar range:
- A shorter time since diagnosis (the pancreas tends to retain more insulin-producing capacity early on).
- A larger, sustained reduction in body weight.
- Lower starting HbA1c, or diabetes managed on fewer medicines.
- Ongoing lifestyle change — diet, physical activity and sleep — alongside any medicine.
None of these guarantees remission, and whether Mounjaro is clinically appropriate for you is a decision for a GPhC-registered prescriber after a consultation. You can begin with a free online eligibility check.
Is Mounjaro licensed for type 2 diabetes in the UK?
Yes — tirzepatide holds an MHRA marketing authorisation for type 2 diabetes and, separately, for weight management. The two licences cover different uses, and a prescriber decides which applies to your situation and whether treatment is suitable at all.
Being licensed does not mean it is right for everyone. Mounjaro is a prescription-only medicine, and under UK rules it can be supplied only after a clinical consultation confirms it is appropriate and safe for you.
Who should not take Mounjaro?
Mounjaro is not suitable for everyone. You should not take it if any of the following apply:
- You are pregnant, planning pregnancy or breastfeeding.
- You have type 1 diabetes.
- You have a personal or family history of medullary thyroid carcinoma, or MEN2.
- You have a history of pancreatitis or severe gastrointestinal disease.
- You have an active eating disorder, severe liver or kidney impairment, or a known allergy to tirzepatide.
Eligibility for weight management generally requires being aged 18 or over with a BMI of 30 or more, or a BMI of 27 to 30 with a weight-related condition such as type 2 diabetes, high blood pressure or sleep apnoea.
What are the side effects of Mounjaro?
The most common side effects (affecting more than 1 in 10 people) are nausea, diarrhoea, constipation, vomiting, decreased appetite and fatigue. These are often strongest when the dose increases and tend to ease over time.
Serious but rare risks include severe allergic reaction, acute pancreatitis, severe hypoglycaemia (low blood sugar, more likely if combined with certain other diabetes medicines), severe gastrointestinal disease and worsening diabetic retinopathy. If you take Mounjaro alongside other glucose-lowering drugs, your prescriber may need to adjust them to reduce the risk of low blood sugar.
You can report suspected side effects through the MHRA Yellow Card scheme at https://yellowcard.mhra.gov.uk/.
How does Mounjaro compare with other options?
Mounjaro acts on two gut-hormone receptors (GLP-1 and GIP), while semaglutide-based treatments act on GLP-1 alone. For blood sugar and weight, the right choice depends on your health, medical history and preferences, not on headline figures alone.
| Medicine | How it's taken | Trial weight-loss figure |
|---|---|---|
| Mounjaro (tirzepatide) | Weekly injection | 22.5% at 15mg over 72 weeks (SURMOUNT-1)* |
| Wegovy injection (semaglutide) | Weekly injection | 20.7% at 7.2mg over 72 weeks (STEP UP)* |
| Wegovy Tablet (oral semaglutide) | Daily tablet on an empty stomach | 16.6% at 25mg over 64 weeks (OASIS 4)* |
| Foundayo (orforglipron) | Daily tablet, any time, with or without food | 12.4% at 36mg trial dose over 72 weeks (ATTAIN-1)* |
*These come from different trials and are not head-to-head comparisons. Individual results vary; not everyone reaches this. See all options on the treatments page.
What does it cost in the UK?
The online consultation is free, and you only pay if a treatment is prescribed and you choose to proceed. The monthly cost of Mounjaro depends on your dose:
- 2.5mg — £160
- 5mg — £185
- 7.5mg — £240
- 10mg — £260
- 12.5mg — £275
- 15mg — £295
Medicines at The Weight Clinic are dispensed by our own GPhC-registered pharmacy (North Harrow Pharmacy, GPhC 1034996), which you can confirm on the General Pharmaceutical Council register at pharmacyregulation.org.
This article is for information only and is not a substitute for personalised medical advice. Weight-loss medicines are prescription-only, are not suitable for everyone, and are prescribed only after a clinical consultation with a GPhC-registered prescriber. Individual results vary. Always speak to a UK-registered pharmacist or doctor before starting or changing any prescription medication.
